TSE:COM 138267 (COM.TO) (COM) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day RangeC$2.95▼C$2.9552-Week Range N/AVolume9,197 shsAverage Volume19,585 shsMarket CapitalizationC$102.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get 138267 (COM.TO) alerts: Email Address Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> About 138267 (COM.TO)Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of patients suffering from heart diseases. It offers BRINAVESS (vernakalant (IV)) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; XYDALBA, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections; and TREVYENT for the treatment of pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.Read More Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> COM Stock News HeadlinesMay 29, 2024 | forbes.comConvert Chinese Yuan To Ethiopian BirrApril 30, 2024 | forbes.comConvert Turkish Lira To LiteCoinJuly 27, 2024 | Paradigm Press (Ad)Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.February 3, 2024 | finance.yahoo.comHilton Metal Forging Limited (HILTON.NS)October 2, 2023 | msn.comAryna Sabalenka: "Paula Badosa is my soulmate"September 1, 2023 | finance.yahoo.comBrunswick Exploration Inc. (BRWXF)August 12, 2023 | forbes.comConvert Malaysian Ringgit To New Zealand DollarJune 12, 2023 | forbes.comConvert Trinidad & Tobago Dollar To Guyanaese DollarJuly 27, 2024 | Paradigm Press (Ad)Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.March 21, 2023 | juniorminingnetwork.comLithium Energi Completes Debt Settlements, Creates New Credit Facility, and Closes Private PlacementAugust 18, 2022 | forbes.comNorth Carolina Income Tax Calculator 2021August 16, 2022 | forbes.comOhio Income Tax Calculator 2021July 5, 2022 | forbes.comTennessee Income Tax Calculator 2021July 5, 2022 | forbes.comCalifornia Income Tax Calculator 2021February 15, 2022 | forbes.comMissouri Income Tax Calculator 2021February 15, 2022 | forbes.comKansas Income Tax Calculator 2021January 21, 2022 | msn.com8,640 new Covid cases, 13 deaths FridayJanuary 5, 2022 | au.finance.yahoo.comOphir Asset Management Pty Ltd - Ophir High Conviction Fund (OPH.AX)See More Headlines Receive COM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 138267 (COM.TO) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:COM CUSIPN/A CIKN/A Webwww.cardiome.com Phone+1-604-6776905FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares34,639,000Free FloatN/AMarket CapC$102.19 million OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. William L. Hunter (Age 55)Pres, CEO & Director Ms. Sheila M. Grant MBAChief Operating OfficerMr. David D. McMasters (Age 59)Gen. Counsel Mr. Hugues SachotChief Commercial OfficerMr. Justin A. Renz (Age 46)Chief Financial Officer Key CompetitorsProMetic Life SciencesTSE:PLIVIVO CannabisCVE:ABCNFennec PharmaceuticalsTSE:FRXEmblemCVE:EMCBriaCell TherapeuticsCVE:BCTView All Competitors COM Stock Analysis - Frequently Asked Questions How do I buy shares of 138267 (COM.TO)? Shares of COM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of 138267 (COM.TO) own? Based on aggregate information from My MarketBeat watchlists, some other companies that 138267 (COM.TO) investors own include Aurora Cannabis (ACB), Aphria (APHA), Bombardier, Inc. Class B (BBD.B), Cardiome Pharma (CRME), Macy's (M), Meta Growth (NACNF) and ProMetic Life Sciences (PLI). This page (TSE:COM) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 138267 (COM.TO) Please log in to your account or sign up in order to add this asset to your watchlist. Share 138267 (COM.TO) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
